Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Acura Pharmaceuticals ( (ACUR) ) is now available.
On July 3 and July 18, 2025, Acura Pharmaceuticals received loans totaling $200,000 from Abuse Deterrent Pharma, LLC, contributing to a principal balance of $8,394,279 with accrued interest of approximately $740,000. The company faces potential operational scaling back or bankruptcy if additional financing is not secured by early August 2025, which could lead to a complete loss of shareholder value.
More about Acura Pharmaceuticals
Average Trading Volume: 6,800
Technical Sentiment Signal: Sell
Current Market Cap: $13.2K
For an in-depth examination of ACUR stock, go to TipRanks’ Overview page.
Trending Articles:
- “…Overlook a Lack of Earnings Power”: UBS Analysts Target Intel Stock (NASDAQ:INTC), Stock Gains
- “…Significantly Extend the Reach and Lethality of our Fleet”: Boeing Stock (NYSE:BA) Slips Despite Successful MQ-25A Test
- “Direct Result of Your Feedback….” Microsoft Stock (NASDAQ:MSFT) Slips as The Option to Skip Updates Emerges